ArticleDrugs in context2025

Patterns of treatment and outcomes of patients with metastatic HER2-low breast cancer treated with CDK4/6 inhibitors and hormone therapy.

Federico Sottotetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.